WHO ICTRP trial
A Novel Multi-Epitope Fusion Protein for Serodiagnosis and Clinical Severity…
ChiCTR2600116401 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2600116401 |
|---|---|
| Public title | A Novel Multi-Epitope Fusion Protein for Serodiagnosis and Clinical Severity Assessment of Tuberculosis |
| Scientific title | A Novel Multi-Epitope Fusion Protein for Serodiagnosis and Clinical Severity Assessment of Tuberculosis |
| Primary sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Patients with tuberculosis |
| Interventions | Non-tuberculous pulmonary infection group:None;Pulmonary tuberculosis group:None;Healthy population group:None |
| Registration date | Jan 9, 2026 |
| Target size | Non-tuberculous pulmonary infection group:98;Pulmonary tuberculosis… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: